Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > March 2014

« Previous month Next month »

GSK to invest $166m in manufacturing in Sub-Saharan Africa

31-Mar-2014 - GSK says it intends to build five new drug manufacturing as part of a £130m ($215m) investment in sub-Saharan Africa.

News in brief

Baxter to continue to grow manufacturing network in pharma spin-out

31-Mar-2014 - Baxter says it will spin out its pharma business to form two separate companies by 2015.

Will US track and trace law be enough to stop counterfeiters?

31-Mar-2014 - In light of the implementation of the Drug Quality and Security Act of 2013 in the US, which calls for the phased implementation of electronic tracking down to the package...

US excipients market to rise to $2B by 2018, study finds

31-Mar-2014 - The rapid growth of the US excipients market is going to be driven mostly by rises in polymers, gelatins and sugar alcohols, according to a new study.

People on the Move

Pharma jobs: who's going places?

31-Mar-2014 - People are on the move at Baxter, Merck & Co., Johnson & Johnson, and elsewhere in this week's column.

Hospira adds $60m to Rocky Mount's turnaround in lawsuit settlement

31-Mar-2014 - Hospira has agreed to pay $60m (€44m) to settle a lawsuit related to manufacturing and quality control deficiencies at its Rocky Mount facility, which is already subject to a $200m...


Goodwin and Aspyrian team to deliver cancer-killing drugs by infrared light

27-Mar-2014 - ADC-makers could avoid using costly cytotoxics in antibody-drug conjugates (ADCs) by using near‐infrared (NIR) light to activate targeted cell-killing payloads, says Goodwin who has team up with Aspyrian Therapeutics....


GSK recalls weight-loss drug Alli following evidence of tampering

27-Mar-2014 - GlaxoSmithKline has issued an alert and US voluntary recall of its OTC weight-loss drug Alli after discovering some bottles had been tampered with.

Janssen Button? Will GSK's F1 team up prompt other collaborations?

26-Mar-2014 - GSK has ‘smashed’ production targets at a UK inhaler plant by revving up manufacturing operations with knowhow developed in Formula One pit lanes by partner, McLaren.

EMA to rejig variations procedures and industry contact staff in April

26-Mar-2014 - Pharmaceutical firms working in Europe may need to update their address books next month after more reorganisation at the EMA.

US FDA issues new bioavailability guidelines

25-Mar-2014 - The US FDA has published guidance of how sponsors should best document the bioavailability of products for investigational new drug applications (INDs) and new drug applications (NDAs).

Indian API maker slammed with US FDA Warning over data issues

25-Mar-2014 - Failure in maintaining test and production data has landed an Indian API maker with a Warning Letter from the US Food and Drug Administration (FDA). 

AMRI to acquire CDMO Cedarburg for $41M

25-Mar-2014 - AMRI will acquire Cedarburg Pharmaceuticals for $38.2m (€27.7) in cash, plus $2.8m of assumed liabilities, to expand its API and drug development offerings.

Bioavailability breakthrough key to new cancer drug OKed in Japan

24-Mar-2014 - Japan has become the first country to approve a new cancer pill that treats disease by interfering with DNA replication in tumour cells.

news from Interphex

Lack of investment in production of low margin drugs behind shortages says expert

24-Mar-2014 - The thin profit margins associated with relatively simple sterile products has led to a reluctance to invest in operations and shortages, according to an industry expert.

Drug industry job changes: People on the move

24-Mar-2014 - New hires at Merck Serono, Amgen, Takeda and Fate Therapeutics this week. It's's people column.

UK energy cuts good for pharma, API and chem firms says industry group

20-Mar-2014 - Efforts to cut industrial energy bills in the UK's 2014 Budget have been welcomed by the Chemical Industries Association (CIA), a group whose members include drug and ingredient makers.

Drug firms replaced as Lonza's biggest buyers in 2013

20-Mar-2014 - Drugmakers were replaced by buyers of cosmetics, hygiene and material protection ingredients as Lonza’s biggest customers in 2013 according to a report released by the Swiss CMO today.

UK MHRA scheme will allow compassionate use of unlicensed drugs

20-Mar-2014 - The UK Medicines and Healthcare Products Regulatory Agency (MHRA) will launch a scheme next month to allow doctors to prescribe medicines without a marketing authorisation to patients with life-threatening conditions.

Interphex day 3

Live from Interphex 2014

19-Mar-2014 - .


'Podular' manufacturing to become facility norm within 5 years, say GEA and G-CON

19-Mar-2014 - ‘Podular’ manufacturing systems will dominate facility design within five years, say G-CON and GEA who have teamed with Pfizer to create a flexible, repurposable and portable facility. 


Managing excipient supply needs risk guidance, not ‘fear’ says expert

19-Mar-2014 - US pharmaceutical firms ‘fear change’ and need guidance on assessing safe excipient supply to become more like their European counterparts, says a senior IPEC expert.

Bioavailability Breakthrough: Aegis’ enhancement tech works in pill form

19-Mar-2014 - Aegis Therapeutics claims a technology developed to improve the bioavailability of drugs delivered through the nose has a similar solubility enhancement effect in a solid dosage form.

Novo Nordisk buys rights to Caisson’s drug-extending biotech

18-Mar-2014 - Caisson Biotech has licensed its drug-extending technology for injectables to Novo Nordisk.

Hospira edges closer to completion of Orchid API deal in India

18-Mar-2014 - The Board of Directors at Indian firm Orchid has approved the sale of its API business to Hospira, bringing the acquisition a step closer to completion.

« Previous month Next month »

Key Industry Events


Access all events listing

Our events, Shows & Conferences...